Preventive or screening interventions Mometasone cream, elomet cream, eczema
Conditions
Interventions
Topical mometasone cream contains: mometasone furoate, methylparaben, propylparaben, white soft paraffin, liquid paraffin, cetostearyl alcohol, macrogol cetostearyl ether, propylene glycol, phosphoric
Experimental Drug,Active Comparator Drug
Mometasone cream,Elomet cream
Sponsors
Zuellig Pharma
Eligibility
Sex/Gender
All
Age
18 Years to 60 Years
Inclusion criteria
Inclusion criteria: 1. Age 18-60 years old 2. Diagnosis of eczema for example irritant contact dermatitis, allergic contact dermatitis, atopic dermatitis, seborrheic dermatitis and nummular eczema 3. New lesion of eczema or recurrent eczema that stop topical treatments for 2 weeks or stop systemic treatments for 4 weeks 4. Can follow up at day 0, 7, 14, 21 and 28
Exclusion criteria
Exclusion criteria: 1. Use topical treatments within 2 weeks 2. Use systemic treatments or immunosuppressive drugs within 4 weeks 3. Have others skin infections 4. Pregnancy or breast feeding 5. Allergy to steroid or other components in cream that we use in the research
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Severity of eczema at day 0,7,14,21,28 after the intervention Total sign and symptom (TSS) score | — |
Secondary
| Measure | Time frame |
|---|---|
| Erythema index at day 0,7,14,21,28 after the intervention Calorimeter,Side effects at day 7,14,21,28 after the intervention Patient reported outcome using a questionnaire interview,Patient Satisfaction at day 7,14,21,28 after the intervention visual analogue scale (VAS) | — |
Countries
Thailand
Contacts
Public ContactMontree Udompataikul
SWU skin center
Outcome results
None listed